The fetal fibronectin test evaluates the risk of preterm birth by detecting the leakage of fibronectin in vaginal fluid during pregnancy. A negative result implies low preterm labor risk in the next two weeks, while a positive result suggests increased risk. This test is employed as a part of clinical assessment during pregnancy management.